论文信息 - A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma - 字舞流文

A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

L. Staudt | R. Gascoyne | G. Salles | M. Czuczman | George W. Wright | G. Slack | P. Brousset | P. Zinzani | D. Eberhard | P. M. Williams | I. Lewis | F. Hernandez-Ilizaliturri | C. Lih | T. Witzig | P. Hagner | A. Davies | P. Fustier | M. Trněný | S. Rule | Yandan Yang | N. Wagner-Johnston | K. Linton | A. Thakurta | Dale Song | J. Russo | P. Williams